南京肯特复合材料股份有限公司董事会 2025 年 4 月 21 日 董事会对独立董事独立性自查情况的专项报告 根据《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等要求，南京肯特复合材料股份有限公司（以下简称"公司"）董事会，就公司 2024 年在任独立董事杨春福、严兵、高永如的独立性情况进行评估并出具如下 专项意见： 经核查独立董事杨春福、严兵、高永如的任职经历以及签署的相关自查文件， 上述人员未在公司担任除独立董事以外的任何职务，也未在公司主要股东公司担 任任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独 立客观判断的关系，不存在影响独立董事独立性的情况，公司独立董事符合《上 市公司独立董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号—— 创业板上市公司规范运作》中对独立董事独立性的相关要求。 南京肯特复合材料股份有限公司 ...

南京肯特复合材料股份有限公司 2024 年年度财务报告 2025 年 4 月 1 财务报告 一、审计报告 | 审计意见类型 | 标准的无保留意见 | | --- | --- | | 审计报告签署日期 | 2025 年 04 月 21 日 | | 审计机构名称 | 公证天业会计师事务所（特殊普通合伙） | | 审计报告文号 | 苏公 W[2025]A356 号 | | 注册会计师姓名 | 谢振伟、陆有龙 | 审计报告正文 南京肯特复合材料股份有限公司全体股东： 一、审计意见 我们审计了南京肯特复合材料股份有限公司（以下简称肯特股份）财务报表，包括 2024 年 12 月 31 日的合并及母 公司资产负债表，2024 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公司所有者权益变动表以及相 关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制，公允反映了肯特股份 2024 年 12 月 31 日的合并及母公司财务状况以及 2024 年度的合并及母公司经营成果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的"注册会计师对财 ...

公证天业会计师事务所（特殊普通合伙） 我们接受委托，对后附的南京肯特复合材料股份有限公司（以下简称肯特股份） 2024年度《募集资金存放与实际使用情况的专项报告》（以下简称"募集资金专项报 告"）进行了鉴证。 Gongzheng Tianye Certified Public Accountants, SGP 中国．江苏．无锡 Wuxi．Jiangsu．China 总机：86（510）68798988 Tel：86（510）68798988 传真：86（510）68567788 Fax：86（510）68567788 电子信箱：mail@gztycpa.cn E-mail：mail@gztycpa.cn 募集资金存放与使用情况鉴证报告 苏公W[2025]E1123号 南京肯特复合材料股份有限公司全体股东： 我们按照《中国注册会计师其他鉴证业务准则第3101号－历史财务信息审计或 审阅以外的鉴证业务》的规定执行了鉴证业务。该准则要求我们计划和实施鉴证工 作，以对鉴证对象信息是否不存在重大错报获取合理保证。在鉴证过程中，我们进 行了审慎调查，实施了包括核查会计记录等我们认为必要的程序。我们相信，我们 的鉴证工作为 ...

证券代码：301591 证券简称：肯特股份 公告编号：2025-016 南京肯特复合材料股份有限公司董事会 关于募集资金 2024 年度存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、募集资金基本情况 （一）实际募集资金金额及资金到账情况 2024 年度，公司募集资金使用总额为 163,018,901.22 元，累计已使用募集资金总额 为 163,018,901.22 元。截至 2024 年 12 月 31 日，募集资金专户余额为 199,404,384.05 元。募集资金具体使用情况如下： 单位：人民币元 | 项目 | 金额 | | --- | --- | | 一、募集资金总额 | 408,612,900.00 | | 减：发行费用 | 49,278,409.08 | | 二、募集资金净额 | 359,334,490.92 | | 加：募集资金利息收入减手续费 | 3,088,794.35 | | 三、募集资金使用 | 163,018,901.22 | | 其中：1.密封件与结构件等零部件扩产项目 | 21,221,742.41 ...

南京肯特复合材料股份有限公司 2024 年度非经营性资金占用及其他关联资金往来情况汇总表（续） 法定代表人： 杨文光 主管会计工作负责人： 孙佳青 会计机构负责人：余仕卿 | 非经营性资金 | 资金占用方名称 | 占用方与上市公 | 上市公司核算 | 2024 年期初占 | 2024 | 年度占用累计发 | 2024 | 年度占用资 | 2024 | 年度偿还累 | 2024 | 年期末占 | 占用形成 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 占用 | | 司的关联关系 | 的会计科目 | 用资金余额 | | 生金额（不含利息） | | 金的利息(如有) | | 计发生金额 | | 用资金余额 | 原因 | | | 控股股东、实际 | | | | | | | | | | | | | | | | 控制人及其附 | - | - | - | - | | - | | - | | - | | - | - | - | | 属企业 | | | | | | | ...

Dividend Distribution - The company plans to distribute a cash dividend of 3.20 CNY per 10 shares to all shareholders, based on a total of 84,120,000 shares[3]. - The total cash dividend amount represents 100% of the total profit distribution[200]. - The company plans to distribute a cash dividend of 3.20 CNY per 10 shares, totaling 26,918,400 CNY for the reporting period[200]. - The company's retained earnings as of December 31, 2024, amount to 258,073,204.57 CNY[200]. - The legal surplus reserve extracted according to the Company Law and Articles of Association is 7,346,363.31 CNY[200]. - The company has a minimum cash dividend ratio of 20% for profit distribution during its growth phase[200]. - The total distributable profit for shareholders is determined to be 214,535,489.88 CNY[200]. - The company has not issued any bonus shares or additional shares from capital reserves for this reporting period[200]. - The company has a complete decision-making process and mechanism for its cash dividend policy[200]. - The company ensures that minority shareholders have sufficient opportunities to express their opinions and protect their legal rights[200]. Financial Performance - The company's operating revenue for 2024 was ¥411,573,362.43, representing a 5.57% increase compared to ¥389,842,844.02 in 2023[17]. - The net profit attributable to shareholders for 2024 was ¥72,039,183.91, a decrease of 4.33% from ¥75,299,516.23 in 2023[17]. - The net profit after deducting non-recurring gains and losses was ¥69,946,067.38, down 3.59% from ¥72,552,538.13 in 2023[17]. - The net cash flow from operating activities increased by 62.90% to ¥71,789,554.93 in 2024 from ¥44,068,851.99 in 2023[17]. - Basic earnings per share decreased by 25.21% to ¥0.89 in 2024 from ¥1.19 in 2023[17]. - Total assets at the end of 2024 reached ¥944,417,732.93, an increase of 77.09% from ¥533,302,717.21 at the end of 2023[17]. - The net assets attributable to shareholders increased by 86.22% to ¥874,932,942.31 at the end of 2024 from ¥469,842,163.07 at the end of 2023[17]. - The company reported a total revenue of 62,797 million for the reporting period[164]. - The company achieved total operating revenue of ¥411,573,362.43 in 2024, representing a year-on-year growth of 5.57%[52]. - The net profit for 2024 was ¥72,039,183.91, showing a year-on-year decline of 4.33%[52]. - Total assets at the end of 2024 reached ¥944,417,732.93, marking a significant year-on-year increase of 77.09%[52]. Market and Product Development - The company has not disclosed any new product developments or technological advancements in the current report[3]. - There are no mentions of market expansion or mergers and acquisitions in the current report[3]. - The company operates in the high-performance engineering plastics sector, which is classified under the rubber and plastic products industry[26]. - The engineering plastics industry is supported by national policies aimed at fostering innovation and development in strategic emerging industries[27]. - The demand for engineering plastics is expected to increase significantly due to the upgrading of China's manufacturing industry and the growth of new energy vehicles and 5G technology[33]. - The company has established a strong position in the high-performance engineering plastics market, collaborating with leading global and domestic high-end equipment manufacturers[34]. - The company’s products are widely used in various sectors, including general machinery manufacturing, communication equipment, and medical devices[31]. - The company is positioned to benefit from favorable national policies that encourage the development of high-end sealing products and engineering plastics[29]. - The company specializes in high-performance engineering plastic products, which are widely used in various industries including automotive, medical devices, and semiconductor equipment[53]. - The main product categories include sealing components, fluorine membranes, functional structural parts, corrosion-resistant pipes, insulation components, and granulated materials[55]. - The sealing components business directly serves leading industrial control and valve companies, with products customized to meet specific client needs[56]. - The fluorine membrane products are utilized in communication and aerospace applications, showcasing their high-performance characteristics[68]. Research and Development - The company has a strong patent portfolio, including key inventions such as composite materials and their preparation methods, enhancing its R&D capabilities[37]. - The company is actively expanding its production capacity, with recent completion of acceptance for projects related to high-performance composite materials and sealing components[39]. - The company has established a provincial engineering technology research center, which supports its R&D and testing capabilities in the industry[39]. - The company is engaged in academic and research collaborations to strengthen its technological framework and innovation[38]. - The company has developed proprietary technologies for manufacturing PTFE and PEEK composite materials, which are critical for its product offerings[38]. - The company is focused on enhancing its market share through product innovation and strategic expansion initiatives[35]. - The company has developed various engineering plastics, achieving a continuous working time for some sealing products from 2,000 hours to over 5,000 hours[43]. - The company has a strong focus on R&D, with a dedicated engineering technology research center equipped for over 70 types of material and product testing[42]. - The company has successfully developed a range of specialized products, including corrosion-resistant pipes and sealing products suitable for various harsh environments[48]. - The company has been involved in multiple significant technology innovation projects, enhancing its reputation in the industry[41]. - The company has established long-term cooperative relationships with leading high-end equipment manufacturers, enhancing its brand influence in the market[49]. - The company is developing medical-grade PTFE tubes, focusing on stabilizing technical parameters during various production stages, aiming to enhance its presence in the medical market[108]. - The project on special high polymer materials is progressing as expected, with a focus on developing suitable processing methods for different aggregation states, which will improve the company's capabilities in material and product development[109]. - The company is focusing on the development of various types of special high polymer materials, which will aid in the optimization of mold design and processing parameters[109]. Financial Management and Governance - The report emphasizes the commitment of the board and management to ensure the accuracy and completeness of the financial report[3]. - The financial report is set to be reviewed by the board, ensuring compliance with legal and regulatory standards[3]. - The company has established a complete and independent financial accounting system, enabling it to make independent financial decisions and manage finances for subsidiaries[157]. - As of the report date, the company has no financial dependencies on shareholders or related parties, ensuring clear asset ownership and independence[154]. - The company operates with an independent R&D, procurement, and sales system, allowing it to make market decisions autonomously[158]. - The company has no related party transactions that could lead to unfair competition or conflicts of interest[158]. - The management team, including the general manager and financial director, is fully dedicated to the company and does not hold positions in related enterprises[155]. - The company has established independent decision-making and supervisory bodies in compliance with legal regulations[156]. - The company has no instances of shareholder funds or assets being occupied by related parties[154]. - The company has a governance structure that adheres to relevant laws and regulations, ensuring independent operations and decision-making processes[144]. - The company maintains a transparent information disclosure system, providing equal access to information for all shareholders and fostering effective communication with investors[152]. Employee and Management Structure - The company reported a total of 511 employees at the end of the reporting period, with 416 in the parent company and 95 in major subsidiaries[194]. - The employee composition includes 247 production personnel, 48 sales personnel, 74 technical personnel, 11 financial personnel, and 131 administrative personnel[194]. - The company has a total of 30,537.14 yuan paid for outsourced labor services, with a total of 871.5 hours worked[198]. - The company has 24 employees with a master's degree or above, and 101 with a bachelor's degree[195]. - The company emphasizes a performance-based salary system, linking floating wages to annual business performance and individual work performance[196]. - The company conducts annual training needs assessments and implements targeted training programs based on departmental needs[197]. - The company has established various employee welfare programs, including transportation, holiday benefits, and recreational activities[196]. - Several key management personnel were dismissed on May 21, 2024, including the General Manager and Deputy General Managers, due to personal reasons and job content adjustments[165]. - The company appointed a new General Manager on May 21, 2024, following the dismissal of the previous General Manager[166]. - The company is undergoing a management restructuring with multiple personnel changes, including the appointment of new supervisors and independent directors[166]. - The company plans to expand its market presence and enhance its product offerings through ongoing research and development initiatives[167]. - The company has a focus on technological advancements in composite materials, leveraging the expertise of its board members with extensive backgrounds in engineering and research[168]. - The company aims to improve operational efficiency and strategic alignment through the recent management changes and new appointments[169]. - The company is committed to maintaining high standards of governance with the appointment of independent directors and a diverse board[170]. Strategic Planning and Future Outlook - The report includes a forward-looking statement regarding the company's strategic planning and future initiatives, cautioning investors about potential risks[3]. - The company is actively developing new products in the nuclear power sector, responding to diverse R&D demands and expanding its market presence[111]. - The company is focusing on enhancing the performance of non-metallic sealing materials to meet the specific needs of various industries, including nuclear power and hydrogen energy[110]. - The company plans to continue increasing R&D investment and expanding into new business areas and product categories[99]. - The company aims to establish a complete production process for PTFE medical tubes, which will reduce processing costs and improve economic benefits[108]. - The ongoing development of fluoropolymer tight lining technology is expected to enhance the company's competitiveness in the sealing and corrosion-resistant components market[109]. - The company is focusing on the construction of new sealing components, with an investment of 2.28 million and a 7% growth target[126]. - The overall investment direction for 2024 includes a focus on enhancing production capabilities and expanding market reach[126]. - The company plans to expand its production of fluorine membrane products, targeting a production capacity of 6.32 million units by 2026[126]. - The company aims to enhance production capacity, shorten delivery times, and diversify product offerings in the sealing and functional structural parts sector[135]. - The company targets to expand its business scale in corrosion-resistant pipe fittings and fluorine membranes, focusing on product quality and cost management[136]. - The company plans to increase development efforts in medical devices, new energy vehicles, wind power, nuclear power, semiconductors, and hydrogen energy sectors[136]. - The company intends to strengthen its independent innovation capabilities in high-performance engineering plastic products and expand its product series[136]. - The company aims to participate in cooperative projects that align with its long-term business strategy to enhance its product structure and competitive advantage[136]. Risk Management - The company faces significant risks from fluctuations in the prices of key raw materials, which constitute a large portion of its main business costs, and is implementing cost control measures to mitigate these impacts[138]. - The company is exposed to foreign exchange risks due to its reliance on USD and EUR for import and export transactions, and it employs professionals to monitor exchange rate trends to minimize foreign exchange losses[139]. - The company has established a solid anti-cyclical barrier through cross-industry and cross-regional business layouts, enhancing its resilience against macroeconomic uncertainties[137]. Shareholder Engagement - The company conducted 1 annual general meeting and 2 extraordinary general meetings during the reporting period, ensuring compliance with legal requirements and protecting shareholder rights[145]. - The company held a temporary shareholders' meeting on April 15, 2024, with a participation rate of 49.75%[160]. - The annual shareholders' meeting on May 20, 2024, had a participation rate of 43.51%[160]. - The company maintains independent operational capabilities without reliance on controlling shareholders for product operations[158].

证券代码：301591 证券简称：肯特股份 公告编号：2025-014 南京肯特复合材料股份有限公司 2、会议召集人：南京肯特复合材料股份有限公司（以下简称"公司"）董事 会 3、会议召开的合法、合规性： 公司已于 2025 年 4 月 21 日召开第三届董事会第十四次会议，审议通过了《关 于提请召开 2024 年年度股东大会的议案》，本次会议的召集和召开符合有关法律、 行政法规、部门规章、规范性文件和《公司章程》的有关规定。 4、会议召开的日期和时间： （1）现场会议召开时间：2025 年 5 月 13 日（星期二）14:30 （2）网络投票时间：2025 年 5 月 13 日（星期二） 关于召开 2024 年年度股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1、会议届次：2024 年年度股东大会 通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 5 月 13 日 9:15-9:25，9:30-11:30 和 13:00-15:00； 通过深圳证券交易所互联网投票系统（http://wltp.cnin ...

证券代码： 301591 证券简称：肯特股份 公告编号： 2025-013 南京肯特复合材料股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 南京肯特复合材料股份有限公司（以下简称"公司"）第三届监事会第十二次 会议通知于 2025 年 4 月 11 日以邮件的形式送达全体监事，会议于 2025 年 4 月 21 日在公司会议室召开。会议由监事会主席耿莉敏女士召集及主持，应出席的 监事 3 人，实际出席的监事 3 人。 本次监事会会议召集、召开符合《中华人民共和国公司法》和《中华人民共 和国证券法》等有关法律、行政法规、规范性文件及《南京肯特复合材料股份有 限公司章程》的规定，会议决议合法、有效。 二、监事会会议审议情况 1、审议通过《关于<2024 年度监事会工作报告>的议案》 根据 2024 年度监事会的工作情况，监事会编制了《2024 年度监事会工作报 告》。 具体内容详见公司同日于巨潮资讯网（www.cninfo.com.cn）披露的相关公告。 本议案表决结果为：同意 3 票，反对 0 票，弃权 0 票。 此议案尚需 ...

证券代码：301591 证券简称：肯特股份 公告编号：2025-012 南京肯特复合材料股份有限公司 第三届董事会第十四次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 南京肯特复合材料股份有限公司（以下简称"公司"）第三届董事会第十四次 会议通知于 2025 年 4 月 11 日以邮件的形式送达全体董事，并于 2025 年 4 月 21 日在公司会议室以现场与通讯相结合的方式召开。本次会议由董事长杨文光先生 召集并主持，应出席的董事 9 人，实际出席的董事 9 人。其中胡亚民、鲍晓磊、 潘国光、王长振、高允斌、杨春福、严兵共 7 人通过线上方式参会。公司监事及 高级管理人员列席本次会议。 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等相关法 律、法规以及《南京肯特复合材料股份有限公司章程》（以下简称"《公司章程》"） 的规定。 二、董事会会议审议情况 1、审议通过《关于<2024 年度总经理工作报告>的议案》 公司总经理杨烨女士代表公司管理层，对 2024 年度的工作进行了总结，并 编制了《2024 年度总 ...

证券代码：301591 证券简称：肯特股份 公告编号：2025-017 南京肯特复合材料股份有限公司 关于 2024 年年度利润分配预案的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 1、公司 2024 年度利润分配方案为：以公司 2024 年 12 月 31 日总股本 84,120,000 股为基数向全体股东每 10 股派发现金 3.20 元人民币（含税），共计派发现金 26,918,400.00 元（含税）；本次利润分配不送红股，不以资本公积转增股本。 2、公司披露现金分红方案后，不触及《深圳证券交易所创业板股票上市规则》 第 9.4 条第（八）项规定的可能被实施其他风险警示情形。 一、审议程序 南京肯特复合材料股份有限公司（以下简称"公司"）于 2025 年 4 月 21 日召开 第三届董事会第十四次会议，以 9 票同意、0 票反对、0 票弃权审议通过了《关于 <2024 年度利润分配预案>的议案》。 此议案已经第三届董事会 2025 年第一次独立 董事专门会议及第三届监事会第十二次会议审议通过。 本次利润分配方案尚需提交公司 2024 ...